Cargando…

Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer

AIM: This study aims to assess the clinical influence of enlarged cardiophrenic lymph nodes (CPLN) on staging computed tomography (CT) among patients with advanced ovarian cancer. METHODS: This retrospective cohort study included 320 patients with advanced epithelial ovarian cancer who underwent sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Sisi, Chen, Huizhu, Ning, Gang, Guo, Yingkun, Li, Xuesheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063917/
https://www.ncbi.nlm.nih.gov/pubmed/37007136
http://dx.doi.org/10.3389/fonc.2023.1149139
_version_ 1785017795873865728
author Song, Sisi
Chen, Huizhu
Ning, Gang
Guo, Yingkun
Li, Xuesheng
author_facet Song, Sisi
Chen, Huizhu
Ning, Gang
Guo, Yingkun
Li, Xuesheng
author_sort Song, Sisi
collection PubMed
description AIM: This study aims to assess the clinical influence of enlarged cardiophrenic lymph nodes (CPLN) on staging computed tomography (CT) among patients with advanced ovarian cancer. METHODS: This retrospective cohort study included 320 patients with advanced epithelial ovarian cancer who underwent staging CT from May 2008 to January 2019. The CPLN diameter was the average of two radiologists’ measurements. Enlarged CPLN was defined as a short-axis diameter of ≥5 mm. Clinical and imaging findings, management decisions, and progression-free survival(PFS) were compared between patients with and without enlarged CPLN. RESULTS: Enlarged CPLN was found in 129 (40.3%) patients, which was significantly associated with more pelvic peritoneal carcinomatosis (odds ratio [OR]: 6.61 with 95% confidence interval [CI]: 1.51–28.99), and involved the greater omentum (OR: 6.41, 95% CI: 3.05–13.46), spleen capsule nodules (OR: 2.83, 95% CI: 1.58–5.06), and liver capsule nodules (OR: 2.55, 95% CI: 1.57–4.17). The optimal cytoreduction rates did not differ between patients with and without enlarged CPLN (p = 0.656). The presence of enlarged CPLN had a significant negative influence on PFS (median PFS, 23.5 vs. 80.6 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.023) in patients with no RD after primary debulking surgery, but no adverse effect on PFS among patients with RD (median PFS, 28.0 vs. 24.4 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.359). However, enlarged CPLN on staging CT did not affect PFS in patients treated with neoadjuvant chemotherapy, with (median PFS, 22.4 vs. 23.6 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.360) or without RD (median PFS, 17.7 vs. 23.3 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.400). The enlarged CPLN showed a decreased trend in 81.6% (n = 80) of the patients with enlarged CPLN. No significant difference was found in PFS (p = 0.562) between patients with decreased and increased in the size of CPLN. CONCLUSIONS: Enlarged CPLN on staging CT is associated with more abdominal disease but is not reliable in predicting complete resection. Enlarged CPLN awareness is necessary for patients with a primary chance of complete resection of abdominal disease.
format Online
Article
Text
id pubmed-10063917
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100639172023-04-01 Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer Song, Sisi Chen, Huizhu Ning, Gang Guo, Yingkun Li, Xuesheng Front Oncol Oncology AIM: This study aims to assess the clinical influence of enlarged cardiophrenic lymph nodes (CPLN) on staging computed tomography (CT) among patients with advanced ovarian cancer. METHODS: This retrospective cohort study included 320 patients with advanced epithelial ovarian cancer who underwent staging CT from May 2008 to January 2019. The CPLN diameter was the average of two radiologists’ measurements. Enlarged CPLN was defined as a short-axis diameter of ≥5 mm. Clinical and imaging findings, management decisions, and progression-free survival(PFS) were compared between patients with and without enlarged CPLN. RESULTS: Enlarged CPLN was found in 129 (40.3%) patients, which was significantly associated with more pelvic peritoneal carcinomatosis (odds ratio [OR]: 6.61 with 95% confidence interval [CI]: 1.51–28.99), and involved the greater omentum (OR: 6.41, 95% CI: 3.05–13.46), spleen capsule nodules (OR: 2.83, 95% CI: 1.58–5.06), and liver capsule nodules (OR: 2.55, 95% CI: 1.57–4.17). The optimal cytoreduction rates did not differ between patients with and without enlarged CPLN (p = 0.656). The presence of enlarged CPLN had a significant negative influence on PFS (median PFS, 23.5 vs. 80.6 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.023) in patients with no RD after primary debulking surgery, but no adverse effect on PFS among patients with RD (median PFS, 28.0 vs. 24.4 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.359). However, enlarged CPLN on staging CT did not affect PFS in patients treated with neoadjuvant chemotherapy, with (median PFS, 22.4 vs. 23.6 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.360) or without RD (median PFS, 17.7 vs. 23.3 months, respectively, CPLN ≥5 mm versus <5 mm; p = 0.400). The enlarged CPLN showed a decreased trend in 81.6% (n = 80) of the patients with enlarged CPLN. No significant difference was found in PFS (p = 0.562) between patients with decreased and increased in the size of CPLN. CONCLUSIONS: Enlarged CPLN on staging CT is associated with more abdominal disease but is not reliable in predicting complete resection. Enlarged CPLN awareness is necessary for patients with a primary chance of complete resection of abdominal disease. Frontiers Media S.A. 2023-03-17 /pmc/articles/PMC10063917/ /pubmed/37007136 http://dx.doi.org/10.3389/fonc.2023.1149139 Text en Copyright © 2023 Song, Chen, Ning, Guo and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Song, Sisi
Chen, Huizhu
Ning, Gang
Guo, Yingkun
Li, Xuesheng
Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
title Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
title_full Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
title_fullStr Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
title_full_unstemmed Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
title_short Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer
title_sort clinical significance of enlarged cardiophrenic lymph nodes by ct in advanced ovarian cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063917/
https://www.ncbi.nlm.nih.gov/pubmed/37007136
http://dx.doi.org/10.3389/fonc.2023.1149139
work_keys_str_mv AT songsisi clinicalsignificanceofenlargedcardiophreniclymphnodesbyctinadvancedovariancancer
AT chenhuizhu clinicalsignificanceofenlargedcardiophreniclymphnodesbyctinadvancedovariancancer
AT ninggang clinicalsignificanceofenlargedcardiophreniclymphnodesbyctinadvancedovariancancer
AT guoyingkun clinicalsignificanceofenlargedcardiophreniclymphnodesbyctinadvancedovariancancer
AT lixuesheng clinicalsignificanceofenlargedcardiophreniclymphnodesbyctinadvancedovariancancer